Using KomPas+ in the Treatment of Patients With Intermittent Claudication

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2271 participants.

Also called NCT05232474

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,271 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05232474
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05232474. Randomized; no masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2024-06-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Using KomPas+ in the Treatment of Patients With Intermittent Claudication
Condition
Peripheral Arterial Disease
Intervention (Device)
KomPas+
Intervention (Device)
KomPas
Lead sponsor
Radboud University Medical Center (class: other)
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (class: other)
Collaborator
Chronisch ZorgNet (class: not stated)
Collaborator
Koninklijk Nederlands Genootschap voor Fysiotherapie (class: not stated)
Collaborator
Vereniging van Oefentherapeuten Cesar en Mensendieck (class: not stated)
Collaborator
Harteraad (class: not stated)

Record details

Record id
cardio:ct-nct05232474
Content hash
de2618024ac9c0741fe3e56c20fed310fa89d059575c698a5afe8755e8aa4d1f